Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Dextroamphetamine is a central nervous system (CNS) stimulant and enantiomer of amphetamine that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is also used illicitly to enhance cognitive and athletic performance, and recreationally as an aphrodisiac and euphoriant. Dextroamphetamine is generally regarded…
History, Community, Culture & Applications
Explore the main themes, entities and connections around Dextroamphetamine. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
amphetamine effects doses use drug adhd addiction also dopamine treatment therapeutic stimulant symptoms may used high review available narcolepsy δfosb
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Dextroamphetamine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Dextroamphetamine | Addiction liability | Moderate | 1.00 | infobox |
| Dextroamphetamine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Dextroamphetamine | ATC code | N06BA02 (WHO) | 1.00 | infobox |
| Dextroamphetamine | Bioavailability | Oral: ~90% | 1.00 | infobox |
| Dextroamphetamine | Boiling point | 201.5 °C (394.7 °F) | 1.00 | infobox |
| Dextroamphetamine | CAS Number | 51-64-9 Y | 1.00 | infobox |
| Dextroamphetamine | ChEBI | CHEBI:4469 Y | 1.00 | infobox |
| Dextroamphetamine | ChEMBL | ChEMBL612 Y | 1.00 | infobox |
| Dextroamphetamine | ChemSpider | 5621 Y | 1.00 | infobox |
| Dextroamphetamine | Chirality | Dextrorotatory enantiomer | 1.00 | infobox |
| Dextroamphetamine | CompTox Dashboard (EPA) | DTXSID8022907 | 1.00 | infobox |
| Dextroamphetamine | Density | 0.913 g/cm3 | 1.00 | infobox |
| Dextroamphetamine | Dependence liability | Physical: None Psychological: Moderate | 1.00 | infobox |
| Dextroamphetamine | Drug class | Stimulant | 1.00 | infobox |
| Dextroamphetamine | DrugBank | DB01576 Y | 1.00 | infobox |
| Dextroamphetamine | Duration of action | IR dosing: 3–6 hours XR dosing: 8–12 hours | 1.00 | infobox |
| Dextroamphetamine | ECHA InfoCard | 100.000.103 | 1.00 | infobox |
| Dextroamphetamine | Elimination half-life | 9–11 hours pH-dependent: 7–34 hours | 1.00 | infobox |
| Dextroamphetamine | Excretion | Kidney (45%);[failed verification] urinary pH-dependent | 1.00 | infobox |
| Dextroamphetamine | Formula | C9H13N | 1.00 | infobox |
| Dextroamphetamine | IUPHAR/BPS | 2147 | 1.00 | infobox |
| Dextroamphetamine | KEGG | D03740 Y | 1.00 | infobox |
| Dextroamphetamine | Legal status | AU: S8 (Controlled drug) | 1.00 | infobox |
| Dextroamphetamine | Legal status | BR: Class A3 (Psychoactive drugs) | 1.00 | infobox |
| Dextroamphetamine | Legal status | CA: ℞-only / Schedule G (CDSA I) | 1.00 | infobox |
| Dextroamphetamine | Legal status | DE: Anlage III (Special prescription form required) | 1.00 | infobox |
| Dextroamphetamine | Legal status | UK: Class B | 1.00 | infobox |
| Dextroamphetamine | Legal status | US: Schedule II | 1.00 | infobox |
| Dextroamphetamine | Legal status | UN: Psychotropic Schedule II | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.